Related Experiment Videos
Pulmonary infection with M. kansasii in a renal transplant patient
Nephron
|January 1, 1980
Abstract:
A 24-year-old man developed a severe pleuropulmonary infection with Mycobacterium kansasii 18 months after receiving a kidney transplant from his mother. Intestinal malabsorption with severe diarrhea and a skin abscess disappeared and his pneumonia was cured when Rifampin was administered. This suggested that generalized dissemination with M. kansasii may have been present.
Insights
A kidney transplant recipient developed a severe lung infection from Mycobacterium kansasii. Treatment with Rifampin cured the pneumonia, suggesting widespread dissemination of the bacteria.
Area of Science:
- Infectious Diseases
- Pulmonology
- Nephrology
Background:
- Post-transplant infections pose significant risks to recipients.
- Mycobacterium kansasii is an opportunistic pathogen.
- Kidney transplantation requires long-term immunosuppression, increasing susceptibility to infections.
Observation:
- A 24-year-old male kidney transplant recipient presented with severe pleuropulmonary infection.
- The infection was caused by Mycobacterium kansasii, identified 18 months post-transplant.
- The patient also exhibited symptoms of intestinal malabsorption, severe diarrhea, and a skin abscess.
Findings:
- Administration of Rifampin led to the resolution of pneumonia.
- Intestinal malabsorption, diarrhea, and the skin abscess also resolved with Rifampin treatment.
- The patient's clinical improvement suggested a generalized dissemination of Mycobacterium kansasii.
Implications:
- Rifampin can be effective in treating disseminated Mycobacterium kansasii infections in immunocompromised individuals.
- This case highlights the importance of considering disseminated atypical mycobacterial infections in transplant recipients with severe, multi-systemic symptoms.
- Early diagnosis and appropriate antimicrobial therapy are crucial for managing severe infections in kidney transplant patients.